Premium
Recommendations of the 5th Canadian Consensus Conference on the diagnosis and treatment of dementia
Author(s) -
Ismail Zahinoor,
Black Sandra E.,
Camicioli Richard,
Chertkow Howard,
Herrmann Nathan,
Laforce Robert,
MonteroOdasso Manuel,
Rockwood Kenneth,
RosaNeto Pedro,
Seitz Dallas,
Sivananthan Saskia,
Smith Eric E.,
Soucy JeanPaul,
Vedel Isabelle,
Gauthier Serge
Publication year - 2020
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1002/alz.12105
Subject(s) - dementia , psychosocial , consensus conference , vascular dementia , medicine , neuroimaging , psychiatry , psychological intervention , cognitive impairment , disease , cognition , intensive care medicine , psychology , pathology
Since 1989, four Canadian Consensus Conferences on the Diagnosis and Treatment of Dementia (CCCDTD) have provided evidence‐based dementia guidelines for Canadian clinicians and researchers. We present the results of the 5th CCCDTD, which convened in October 2019, to address topics chosen by the steering committee to reflect advances in the field, and build on previous guidelines. Topics included: (1) utility of the National Institute on Aging research framework for clinical Alzheimer's disease (AD) diagnosis; (2) updating diagnostic criteria for vascular cognitive impairment, and its management; (3) dementia case finding and detection; (4) neuroimaging and fluid biomarkers in diagnosis; (5) use of non‐cognitive markers of dementia for better dementia detection; (6) risk reduction/prevention; (7) psychosocial and non‐pharmacological interventions; and (8) deprescription of medications used to treat dementia. We hope the guidelines are useful for clinicians, researchers, policy makers, and the lay public, to inform a current and evidence‐based approach to dementia.